(Q46495042)

22 December 2017

title

Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma (English)

1 reference

22 December 2017

1 reference

1

1 reference

22 December 2017

Bastian Keck

Bastian Keck

7

0 references

Helge Taubert

Helge Taubert

6

0 references

Friedrich Grässer

13

Friedrich A Grässer

1 reference

22 December 2017

Arndt Hartmann

10

Arndt Hartmann

1 reference

22 December 2017

author name string

Elke Nolte

2

1 reference

22 December 2017

Martin Hart

3

1 reference

22 December 2017

Celina Döll

4

1 reference

22 December 2017

Sven Wach

5

1 reference

22 December 2017

Elisabeth Kremmer

8

1 reference

22 December 2017

Robert Stöhr

9

1 reference

22 December 2017

Wolf Wieland

11

1 reference

22 December 2017

Bernd Wullich

12

1 reference

22 December 2017

language of work or name

English

0 references

publication date

3 August 2012

1 reference

22 December 2017

International Journal of Cancer

published in

1 reference

22 December 2017

volume

132

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

775-784

1 reference

22 December 2017

Hallmarks of Cancer: The Next Generation

cites work

1 reference

MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation

21 January 2018

1 reference

miRNAs get an early start on translational silencing

21 January 2018

1 reference

The microRNA profile of prostate carcinoma obtained by deep sequencing

21 January 2018

1 reference

Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.

21 January 2018

1 reference

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.

21 January 2018

1 reference

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

21 January 2018

1 reference

Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes

21 January 2018

1 reference

Proteomic identification of differentially-expressed proteins in squamous cervical cancer

21 January 2018

1 reference

The candidate oncogene ZNF217 is frequently amplified in colon cancer.

21 January 2018

1 reference

Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors

21 January 2018

1 reference

ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction

21 January 2018

1 reference

A novel class of RanGTP binding proteins

21 January 2018

1 reference

Angiogenesis inhibitors in the treatment of prostate cancer

21 January 2018

1 reference

Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.

21 January 2018

1 reference

The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum

21 January 2018

1 reference

microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma

21 January 2018

1 reference

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

Loss of mir-146a function in hormone-refractory prostate cancer

21 January 2018

1 reference

Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation

21 January 2018

1 reference

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma

21 January 2018

1 reference

Suppression of cell growth and invasion by miR-205 in breast cancer

21 January 2018

1 reference

Urine markers in monitoring for prostate cancer.

21 January 2018

1 reference

Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation

21 January 2018

1 reference

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach

21 January 2018

1 reference

Transport of hypoxia-inducible factor HIF-1alpha into the nucleus involves importins 4 and 7.

21 January 2018

1 reference

MicroRNA-22 regulates hypoxia signaling in colon cancer cells

21 January 2018

1 reference

Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma

21 January 2018

1 reference

DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma

21 January 2018

1 reference

Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target

21 January 2018

1 reference

Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression.

21 January 2018

1 reference

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

21 January 2018

1 reference

Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3

21 January 2018

1 reference

Genome-Wide Copy Number Analysis in Esophageal Adenocarcinoma Using High-Density Single-Nucleotide Polymorphism Arrays

21 January 2018

1 reference

MicroRNAs and prostate cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27731

1 reference

22 December 2017

1 reference

22 December 2017